Bruguiera parviflora (bruguiera_parviflora)
/
Imported from atlas release summary for Bruguiera parviflora.
1110
Candidate Genes
104
Families
6
Pathways
Phylogenetic Position
The current species is positioned within the lineage framework used by this site. Its taxon group is highlighted below.
Species Metadata
Taxon group
Eudicots
Common name
/
Genome status
Genome-level resource available
Site Placement
- This page summarizes pathway coverage, family distributions, and the gene list for the species within the current public dataset.
- If you want to start from the public overview first, open the homepage and then return here for species-level drill-down.
- Family statistics correspond to enzyme families, while pathway statistics correspond to the real category-level pathways.
Pathway Coverage
6
Pathways
Family Distribution
1110
Candidate Genes
BAHD
6.42%
C4H
6.24%
C3'H/CYP98A
5.89%
4CL
4.63%
POD
4.17%
CYP76
3.79%
IFS
3.68%
UGT
3.58%
Other Families
61.61%
More Families (96)
UFGT
93
3.26%
T3O
92
3.23%
7DLGT
90
3.16%
F3H
80
2.81%
NMT
73
2.56%
DWF4/CYP90B1
65
2.28%
CODM/T6ODM
53
1.86%
F3'H/CYP75B
53
1.86%
STR
50
1.75%
CAD
41
1.44%
IFR
39
1.37%
CYP71
37
1.3%
H6H
36
1.26%
SMT1/SMT2/SMT3
36
1.26%
BR6OX2/CYP85A2
36
1.26%
CYP90D1
35
1.23%
CAS
34
1.19%
TRI/TRII
32
1.12%
PYKS
30
1.05%
HCT
30
1.05%
LAC
29
1.02%
TPS
29
1.02%
PMT
28
0.98%
GES
28
0.98%
CSE
25
0.88%
GS
24
0.84%
T16H
24
0.84%
SGD
23
0.81%
ANR
23
0.81%
IO
22
0.77%
G8O/G8H
22
0.77%
COMT
22
0.77%
TAT
22
0.77%
FNS
20
0.7%
F3'5'H/CYP75A
18
0.63%
SLS
17
0.6%
7DLH
17
0.6%
CCR
17
0.6%
RAS
16
0.56%
COR
15
0.53%
PAL
15
0.53%
CYP51G1
14
0.49%
16OMT
11
0.39%
BR6OX1/CYP85A1
11
0.39%
BBE
10
0.35%
F5H/CYP84A
10
0.35%
CPD/CYP90A1
10
0.35%
8HGO
9
0.32%
ROT3/CYP90C1
9
0.32%
CHS
8
0.28%
CPR
8
0.28%
AACT
8
0.28%
NCS
7
0.25%
LAMT
7
0.25%
CYP80B1
7
0.25%
ANS/LDOX
7
0.25%
DFR
7
0.25%
CCoAOMT
7
0.25%
GGPPS
7
0.25%
CYP719
6
0.21%
CNMT
6
0.21%
HPPR
6
0.21%
MPO
5
0.18%
SQS/FDFT1
5
0.18%
MVD
5
0.18%
DXS
5
0.18%
TDC
4
0.14%
XMT_MXMT_DXMT
4
0.14%
SMO1/SMO2
4
0.14%
MVK
4
0.14%
MCT/IspD
4
0.14%
FPPS
4
0.14%
ADC
3
0.11%
TYDC_DDC
3
0.11%
DET2
3
0.11%
HYD1
3
0.11%
HDR/IspH
3
0.11%
6OMT_4OMT_SOMT
2
0.07%
ISY
2
0.07%
FLS
2
0.07%
CHI
2
0.07%
DWF7
2
0.07%
DWF5
2
0.07%
SQE
2
0.07%
HMGR
2
0.07%
IDI
2
0.07%
DXR
2
0.07%
HDS/IspG
2
0.07%
MDS/IspF
2
0.07%
HMGS
2
0.07%
CYP80F1
1
0.04%
FK
1
0.04%
DWF1
1
0.04%
CPI1
1
0.04%
CMK/IspE
1
0.04%
PMK
1
0.04%
Species Pathway Results
The links below show identification results for this species within each pathway, instead of opening the global pathway overview.
| Pathway | Candidate Genes | Families | Top family | Results |
|---|---|---|---|---|
| Terpenoid pathway | 324 | 19 | BAHD (137) | View species results |
| Alkaloid pathway | 235 | 19 | 7DLGT (37) | View species results |
| Phenylpropanoid pathway | 228 | 11 | POD (97) | View species results |
| Flavonoid pathway | 152 | 10 | UFGT (87) | View species results |
| Rosmarinic acid pathway | 104 | 7 | C4H (34) | View species results |
| Steroid pathway | 67 | 12 | CAS (31) | View species results |
Broad Catalytic Groups
P450/oxygenase and BAHD/acyltransferase are counted separately as broad catalytic groups and are not mixed into the canonical enzyme-family count.
| Catalytic group | Families | Candidate genes | Included families |
|---|---|---|---|
| P450/oxygenase | 24 | 1065 | 7DLH, BR6OX1/CYP85A1, BR6OX2/CYP85A2, C3'H/CYP98A, C4H, CPD/CYP90A1, CYP51G1, CYP71, CYP719, CYP76, CYP80B1, CYP80F1, CYP90D1, DWF4/CYP90B1, F3'5'H/CYP75A, F3'H/CYP75B, F5H/CYP84A, G8O/G8H, IFS, IO, ROT3/CYP90C1, SLS, T16H, T3O |
| BAHD/acyltransferase | 3 | 229 | BAHD, HCT, RAS |
Identification Result List
Search the public identification results for this species; click pathway or family legends above to narrow within this species.
Current pathway filter: Steroid pathway
| Gene | Pathway | Family | Confidence | Status |
|---|---|---|---|---|
| bruguiera_parviflora_evm.model.Scaffold_1.428 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_10.13 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_11.489 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_12.660 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_13.110 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_13.114 | Steroid | CAS | low | borderline |
| bruguiera_parviflora_evm.model.Scaffold_13.4 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_16.719 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_1648.1 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_2.1358 | Steroid | CAS | low | borderline |
| bruguiera_parviflora_evm.model.Scaffold_2.1514 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_2284.1 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_3.799 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_32.10 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_33.9 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_3696.1 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_38.8 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_5.24 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_5.737 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_6.589 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_6.907 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_686.1 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_7.1300 | Steroid | CAS | low | borderline |
| bruguiera_parviflora_evm.model.Scaffold_7.1301 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_8.74 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_8.79 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_8.81 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_9.1104 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_9.13 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_9.435 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_9.773 | Steroid | CAS | medium | pass |
| bruguiera_parviflora_evm.model.Scaffold_1.1714 | Steroid | CPD/CYP90A1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_10.10 | Steroid | CPD/CYP90A1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_16.228 | Steroid | CPD/CYP90A1 | low | borderline |
| bruguiera_parviflora_evm.model.Scaffold_16.511 | Steroid | CPD/CYP90A1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_2.719 | Steroid | CPD/CYP90A1 | low | borderline |
| bruguiera_parviflora_evm.model.Scaffold_2005.1 | Steroid | CPD/CYP90A1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_6.31 | Steroid | CPD/CYP90A1 | low | borderline |
| bruguiera_parviflora_evm.model.Scaffold_69.9 | Steroid | CPD/CYP90A1 | low | borderline |
| bruguiera_parviflora_evm.model.Scaffold_7.377 | Steroid | CPD/CYP90A1 | low | borderline |
| bruguiera_parviflora_evm.model.Scaffold_7.500 | Steroid | CPD/CYP90A1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_4.282 | Steroid | CPI1 | high | pass |
| bruguiera_parviflora_evm.model.Scaffold_1062.2 | Steroid | CYP51G1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_11.838 | Steroid | CYP51G1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_12.71 | Steroid | CYP51G1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_14.270 | Steroid | CYP51G1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_15.735 | Steroid | CYP51G1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_17.24 | Steroid | CYP51G1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_3.105 | Steroid | CYP51G1 | medium | borderline |
| bruguiera_parviflora_evm.model.Scaffold_4.1753 | Steroid | CYP51G1 | medium | borderline |